Harrow, Inc. (HROW)
54.18
+0.19
(+0.35%)
USD |
NASDAQ |
Feb 27, 16:00
54.25
+0.07
(+0.13%)
After-Hours: 20:00
Harrow Research and Development Expense (TTM) : 13.97M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 254.91M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Xeris Biopharma Holdings, Inc. | 29.38M |
| Stoke Therapeutics, Inc. | 117.76M |
| Vir Biotechnology, Inc. | 432.80M |